Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: KRAS-Mutant Non-Small Cell Lung Cancer

Featuring perspectives from Dr Alexander Spira, including the following topics: KRAS mutations in patients with non-small cell lung cancer (NSCLC) (0:00) KRAS small-molecule inhibitors combined with targeted therapy or immunotherapy for patients with NSCLC (3:49) KRAS small-molecule inhibitors in patients with NSCLC and brain metastases (10:52) Future role of KRAS small-molecule inhibitors as adjuvant or neoadjuvant therapy for patients with localized NSCLC (12:21) Comparing and contrasting KRAS small-molecule inhibitors for NSCLC (14:56) Future directions in targeting KRAS and other mutations (20:32) Using liquid biopsy to detect KRAS-mutated NSCLC (33:01) Common misperceptions about targeting KRAS G12C in NSCLC (35:43) CME information and select publications